GlassScriptPrepare for your visit
Abdul Thannoun
Gastroenterology (Internal Medicine) · Amarillo, TX · NPI 1962438713
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$749.79
in general payments reported to CMS, 2019-2025 · $172 in 2025
The $172 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Who reported paying
General payments only, top 6 by amount.
- Boston Scientific Corporation $275.06
- Amgen INC. $116.64
- Olympus America INC. $116.46
- Janssen Biotech, INC. $98.81
- Glaxosmithkline, LLC. $55.35
- Lumendi LLC $51.61
Drugs and devices associated with these payments
Uplizna Stelara Tremfya Shingrix Arexvy Resolution 360 Clip Spyglass Cre Pro
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Abdul Thannoun listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/88481/abdul-thannoun